Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dosing Frequency of Low-Dose Atropine on Myopia Progression in Adolescents
ChiCTR2600125416Phase 4Completed
- Sponsor
- Shanxi Aier Eye Hospital
- Start
- May 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atropine in myopia (4 arms), sponsored by Shanxi Aier Eye Hospital. Primary endpoints: Spherical equivalent and Axial length. Started May 2026; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2600125416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125416.